Neurocrine Biosciences (NBIX) Tops Q4 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Neurocrine Biosciences (NBIX) Tops Q4 EPS by 30c

Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2019 Financial Results

February 4, 2020 4:01 PM EST

SAN DIEGO, Feb. 4, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the fourth quarter and full-year ended December 31, 2019 and provided full-year 2020 financial expense guidance.

"I am very pleased with the accomplishments of Neurocrine Biosciences this past year, including our quarterly and full-year business results. We anticipate an exciting year... More